Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice

PURPOSE: The NSABP Trial B-31 and NCCTG Trial N9831 (B-31/N9831 trials, Romond et al. in N Engl J Med 353:1673–84, 2005. doi:10.1056/NEJMoa052122; Perez et al. in J Clin Oncol 32:3744–52, 2014. doi:10.1200/JCO.2014.55.5730) established the efficacy of adjuvant trastuzumab for patients with HER2-posi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallagher, Christopher M., More, Kenneth, Masaquel, Anthony, Kamath, Tripthi, Guerin, Annie, Ionescu-Ittu, Raluca, Nitulescu, Roy, Gauthier-Loiselle, Marjolaine, Sicignano, Nicholas, Butts, Elizabeth, Wu, Eric Q., Barnett, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816950/
https://www.ncbi.nlm.nih.gov/pubmed/27047721
http://dx.doi.org/10.1186/s40064-016-2008-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816950/
https://www.ncbi.nlm.nih.gov/pubmed/27047721
http://dx.doi.org/10.1186/s40064-016-2008-9

Ejemplares similares